EPMap-System

About EPMap-System

EPMap-System GmbH, founded in 2014 and headquartered in Herdecke, Germany, operated in the medical diagnostic equipment sector with a focus on electrophysiology (EP). The company was established to develop and distribute technologies for heart diagnostics, specifically for electrophysiology procedures. Dr. Jörg Ströbel served as the managing director, aiming to simplify the daily work of medical staff in electrophysiology to prioritize patient treatment and health.

The firm's core offering was the EPPerfect system, an integrated solution for recording, stimulation, and 3D navigation and mapping of the heart. This system included a signal recording and pacing system, a radiofrequency ablation generator, and an irrigation pump. It was designed to provide hospitals with high-density mapping capabilities and the ability to tag anatomical structures. The EPPerfect Ablation Generator featured an output power of 100W, a temperature measurement range of 30-90°C, and could handle catheters from various major vendors. The business operated in the HealthTech and Life Sciences verticals, targeting a market for electroanatomical mapping that was valued at USD 1.8 billion in 2022 and projected to grow.

EPMap-System was a privately held, venture-capital-backed company. Over its operational history, it raised approximately $25 million in funding, with a Series A round in October 2019. Despite its developments and market presence, the company faced financial difficulties, leading to bankruptcy and liquidation proceedings which were completed on January 25, 2021. Following this, the company is listed as "Out of Business".